Patient perception of dyskinesia in Parkinson's disease

被引:42
|
作者
Hung, S. W. [2 ,3 ]
Adeli, G. M. [2 ]
Arenovich, T. [4 ]
Fox, S. H. [2 ]
Lang, A. E. [1 ,2 ]
机构
[1] Univ Toronto, Movement Disorders Ctr, Div Neurol, Toronto, ON M5T 2S8, Canada
[2] Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada
[3] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA
[4] Ctr Addict & Mental Hlth, Dept Clin Res, Toronto, ON, Canada
来源
关键词
QUALITY-OF-LIFE; LEVODOPA; ROPINIROLE; TRIAL; PRAMIPEXOLE; PREVALENCE; 5-YEAR;
D O I
10.1136/jnnp.2009.173286
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.
引用
下载
收藏
页码:1112 / 1115
页数:4
相关论文
共 50 条
  • [21] Therapy found for Parkinson's disease dyskinesia
    Bradbury, J
    LANCET, 2003, 361 (9370): : 1712 - 1712
  • [22] Patient and provider perception of video telehealth in Parkinson's disease (PD)
    Wilkinson, J. R.
    Korom-Djakovic, D.
    Spindler, M.
    Morley, J.
    Duda, J.
    MOVEMENT DISORDERS, 2015, 30 : S137 - S137
  • [23] A Patient's Guide to Visual Perception Changes That Occur With Parkinson Disease
    Walker, Sadie
    Colletta, Kalea
    Devos, Hannes
    Gaynes, Bruce
    Ellison, Rachael L.
    Alsa-kaji, Rama
    Watters, Kelsey
    Todfield, Alexander
    Chawla, Jasvinder
    Kletzel, Sandra
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2023, 104 (07): : 1165 - 1169
  • [24] Mitochondrial abnormalities in the putamen in Parkinson’s disease dyskinesia
    Alipi V. Naydenov
    Fair Vassoler
    Andrew S. Luksik
    Joanna Kaczmarska
    Christine Konradi
    Acta Neuropathologica, 2010, 120 : 623 - 631
  • [25] Oseltamivir-induced dyskinesia in Parkinson's disease
    Kadowaki, Taro
    Komagamine, Tomoko
    Suzuki, Keisuke
    Hirata, Koichi
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (02) : 133 - 134
  • [26] Levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    Lee, J
    Venderova, K
    JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (03) : 359 - 391
  • [27] Levodopa-induced dyskinesia in Parkinson’s disease
    J. M. Brotchie
    J. Lee
    K. Venderova
    Journal of Neural Transmission, 2005, 112 : 359 - 391
  • [28] Dyskinesia and dystonia induced by levodopa in Parkinson's disease
    Marconi, R
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 2003, 25 (02): : 48 - 50
  • [29] Dyskinesia induced by gabapentin in idiopathic Parkinson's disease
    Raju, Prasanth M.
    Walker, Richard W.
    Lee, Mark A.
    MOVEMENT DISORDERS, 2007, 22 (02) : 288 - 289
  • [30] FACING DYSKINESIA IN PARKINSON'S DISEASE: NONDOPAMINERGIC APPROACHES
    Salamone, J. D.
    DRUGS OF THE FUTURE, 2010, 35 (07) : 567 - 573